SMi Group are delighted to introduce Ophthalmic Drugs which is being held on the 28th - 29th November 2017 at the Copthorne Tara Hotel in London, UK. With the Ophthalmic Drugs market being worth over $37bn in 2026 (Vision Gain), Ophthalmic Drugs 2017 will enable you to explore novel approaches into treatments, new developments in medical devices, drug delivery and pre-clinical and clinical trials in order to deepen your understanding of inherited ocular diseases. Here's a snap shot of our industry leading experts presenting this November: - Naj Sharif, Executive Director in RandD, Head, Global Alliances and External Research, Santen Inc - Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals - Michael Lai, Global Program Medical Director, Novartis - Sergio Leal, Ophthalmologist Director, Global Clinical Leader, Bayer - Victor Chong, Global Head of Ophthalmology, Boehringer Ingelheim Time: 08:00 to 17:00 Price: Standard Price (early-bird rates available): GBP 1499